Ernie Branson/NIH

NIH Could Soon See a Significant Funding Boost From Congress

Health-research advocates are pleasantly surprised by the budget numbers coming out of Congress.

For the National Institutes of Health and its supporters, 2015 could turn out to be a pretty good year.

As Congress continues negotiations on a mammoth omnibus spending package, advocates are hopeful that their favored institution is becoming a congressional priority again—and that an extended period of uncertainty may be coming to a close.

It’s a “different atmosphere than we’ve seen in over a decade” said Mary Woolley, the president of the advocacy group Research!America. In the wake of September 11, she said, national defense and fighting terrorism crowded out research funding. “We took our eyes off the ball collectively on focusing on making sure that research for health—and I would say science broadly for that matter—was adequately supported,” Woolley said. She attributes the change this year to “the steady drumbeat of loss of life.”

“People are saying ‘Enough, we have got to find answers and even if it means we’re gonna spend more money than some would like’ ... it’s worth doing,” Woolley said.

Though the exact figures aren’t yet public, the $1.15 trillion spending bill Congress is haggling over could include the biggest bump in NIH funding in 13 years. NIH funding advocates say they’re gratified how members have rallied around the NIH’s cause this year.

The Senate Appropriations Committee signed off on a $2 billion increase for the NIH earlier this year, for a total budget of $32 billion for fiscal year 2016. On the House side, Appropriations legislators called for a $1.1 billion bump, for a total of $31.2 billion. Negotiations for the omnibus could drag into the weekend. House Speaker Paul Ryan said Tuesday morning that his chamber will pass a short-term continuing resolution to fund the government past the December 11 shutdown deadline.

Congress has a long tradition of supporting biomedical research on a bipartisan basis, even if recent years have seen stagnant budgets. “No one is opposed to medical research,” said Patrick White, the president of the advocacy foundation Act for NIH. “The real challenge is what sort of priority do you give it.”

Advocates like White think members of Congress have, quite simply, shifted their priorities. White said the 2013 shutdown over Obamacare was a turning point in the NIH budget question. “I think that’s when people of all persuasions started to realize that not only were there some government functions that were absolutely worth supporting and keeping open,” White said, “but that NIH had first of all been neglected and second of all was something that was worth reinvesting in.” Members of Congress have also been spooked by significant biomedical investments in countries like China, White said, and conservatives in particular are receptive to arguments framing “public-health security [as] national security.”

The NIH has lost roughly 25 percent of its purchasing power since 2003 and just one in six grants sent to the NIH are funded; those are two metrics Director Francis Collins often cites as evidence of his agency’s ill health. Even after the 2013 shutdown, which hit the NIH’s operations hard and generated bad PR for Congress, there wasn’t an immediate funding reversal. In the 2014 budget, the NIH got a $1 billion bump, though that wasn’t significant enough to thrill research advocates. And last year, the NIH’s funds were bumped 0.5 percent, still below the pre-sequestration budget. “There’s no institute here that feels good about their ability to support the science that they’re asked to look at,” Collins said in an interview with Stat News late last month.

Researchers funded through the NIH are rattled not only because, in their view, the agency is funding an insufficient number of grants, but also because the constant budget battles in Congress generate uncertainty. That makes it hard to plan multiyear research projects, and it discourages young scientists from pursuing publicly funded biomedical research.

It wasn’t always like this. From 1998 to 2003, Congress doubled the NIH’s budget to $27 billion as part of a Republican-led, bipartisan push. In the last few years, Newt Gingrich, who was House speaker when the “doubling” began, has called for much more spending on the NIH:

[W]hen it comes to breakthroughs that could cure—not just treat—the most expensive diseases, government is unique. It alone can bring the necessary resources to bear ... And it is ultimately on the hook for the costs of illness. It’s irresponsible and shortsighted, not prudent, to let financing for basic research dwindle.

This year, congressional legislators have come around on some of those very ideas. Ronald DePinho, the president of the University of Texas MD Anderson Cancer Center and a member of Act for the NIH’s advisory committee, began to see signals in early 2015 that Congress was open to giving the NIH a bump. One was the House’s overwhelming support for the 21st Century Cures bill, which would boost funding for the NIH and the Food and Drug Administration, among other provisions. (The Senate is incorporating elements of the House bill into its own legislation, slated for next year.)

In a November 18 letter to the House Appropriations Committee, roughly 100 Republican and Democratic members of Congress called for “at least” $32 billion in funding for NIH in fiscal year 2016. Some Republicans took it a step farther. In a letter to Republican appropriators and House GOP leadership, more than 100 House Republicans called for “a minimum” of $3 billion.

Senate Labor/HHS Subcommittee Chairman Roy Blunt, who backed a $2 billion increase, “will continue to fight for increasing funding on the omnibus,” his spokesman said Monday.

Advocates are careful to note, however, that a year of improved funding won’t change everything—and that this year’s omnibus still needs to get through Congress. Calling the potential 2016 budget a “step in the right direction,” DePinho said it’d take three years of $3 billion increases each year to get the NIH “back to the waterline.”

Researchers on the ground are hoping for a rebound—and fast. When the NIH struggles, biomedical scientists at universities all over the country don’t see even their best grants getting funded. When those grants aren’t funded, researcherspinch pennies in the lab, cut down on staff, or, in some cases, leave science altogether. Heather Duffy, a former assistant professor of medicine at Harvard Medical School, said she never would’ve left the biomedical research field if the grant-funding climate were better. After crafting 18 different grants one year to appeal to peer reviewers, she had the realization that she wasn’t “even doing science anymore,” and left in 2012.

Plus, funding constraints make scientists less bold, DePinho said. Instead of pitching radical ideas in their grant proposals, they craft the safest pitches possible to get the money they need to run their labs. Benjamin Abella, the vice chair of research in the University of Pennsylvania’s emergency medicine department, said he’s seen researchers “retool” their labs to do more work for pharmaceutical companies to pay the bills. That’s work “that may be less innovative, that may be less exciting, and may be less [about] serving the public,” said Abella, who’s been running his own lab for 10 years.

He’s a professor for residents in Penn’s emergency department and has noticed his students’ disinterest in pursuing research as well. “The more they see of my life, they say, ‘We don’t want to do what you do,’” Abella said. “They just have made the calculus that the quality of life and the amount of effort and the amount of stress” isn’t worth it.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.